Dr. Katherine A. Bell, MD

Dr. Bell practices at U.S. Dermatology Partners in Dallas, Texas.

Dr. Bell's NPI, 1295743607, was assigned on August 3, 2006. Dr. Bell graduated from University of Miami, Miller School of Medicine in 1998. Dr. Bell holds Texas license L0027.

Dr. Bell's primary practice is U.S. Dermatology Partners, at 5310 Harvest Hill Rd, Dallas, TX 75230 in Dallas County. The practice phone is (214) 420-0672.

Dr. Bell's primary practice is U.S. Dermatology Partners in Dallas, Texas. The medical group on file is U.S. Dermatology Partners. Dmand AI also links Dr. Bell to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bell practices. Vendor and product names are available with a free account.

Dermatology is Dr. Bell's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Bell is board certified in dermatology by the American Board of Dermatology. Dr. Bell is licensed in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, facial skin infection and itchy rashes among the conditions Dr. Bell treats.

CMS data shows 4,433 Medicare services from Dr. Bell across 15 procedure codes in 2024, for 680 Medicare patients. Medicare paid $183,603 for them. Every service was in an office.

CMS counts 680 Medicare patients who saw Dr. Bell in 2024. The largest group is 65 to 74, with 360 patients. 75% of them have high cholesterol, and 70% have high blood pressure. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bell's median patient age at 63, with 59% women.

In 2024, Dr. Bell wrote 537 Medicare Part D claims for 264 patients. 96% of them were for generic drugs. CMS names the drug for 440 of them, across 10 drugs with 11 or more claims each, at $11,996 in total drug cost. In 2023, CMS named 304 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Bell for performance year 2024, reported individually. Dr. Bell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 582 procedures of skin biopsy by Dr. Bell, more than 96% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Bell. Dr. Bell's most frequent co-author is Ida Francesca Orengo, MD.

CMS Open Payments shows 375 general payments to Dr. Bell from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $1,261.

Dmand AI lists 1 award for Dr. Bell.

Dr. Bell graduated from University of Miami, Miller School of Medicine in 1998. Dr. Bell is a member of AAD.

Dr. Bell is in network with 22 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.